nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—Taste salty—Liotrix—hypothyroidism	0.0418	0.101	CcSEcCtD
Lithium—GRIA3—nerve—hypothyroidism	0.0318	0.0798	CbGeAlD
Lithium—GRIA3—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0287	0.151	CbGpPWpGaD
Lithium—GSK3B—nerve—hypothyroidism	0.0275	0.0691	CbGeAlD
Lithium—Benign intracranial hypertension—Dextrothyroxine—hypothyroidism	0.0242	0.0588	CcSEcCtD
Lithium—Benign intracranial hypertension—Levothyroxine—hypothyroidism	0.0242	0.0588	CcSEcCtD
Lithium—Hyperthyroidism—Levothyroxine—hypothyroidism	0.018	0.0437	CcSEcCtD
Lithium—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.018	0.0437	CcSEcCtD
Lithium—Benign intracranial hypertension—Liotrix—hypothyroidism	0.0178	0.0433	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.0168	0.0883	CbGpPWpGaD
Lithium—Muscle twitching—Liothyronine—hypothyroidism	0.0148	0.0358	CcSEcCtD
Lithium—GRIA3—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.0142	0.0745	CbGpPWpGaD
Lithium—IMPA1—heart—hypothyroidism	0.0139	0.0349	CbGeAlD
Lithium—Hyperthyroidism—Liotrix—hypothyroidism	0.0133	0.0322	CcSEcCtD
Lithium—IMPA1—cardiovascular system—hypothyroidism	0.0131	0.0329	CbGeAlD
Lithium—GRIA3—adrenal cortex—hypothyroidism	0.0122	0.0307	CbGeAlD
Lithium—IMPA1—gonad—hypothyroidism	0.0119	0.0299	CbGeAlD
Lithium—IMPA2—heart—hypothyroidism	0.0104	0.0262	CbGeAlD
Lithium—IMPA1—blood—hypothyroidism	0.0104	0.026	CbGeAlD
Lithium—GSK3B—heart—hypothyroidism	0.0102	0.0257	CbGeAlD
Lithium—IMPA1—female gonad—hypothyroidism	0.00965	0.0243	CbGeAlD
Lithium—GSK3B—cardiovascular system—hypothyroidism	0.00964	0.0242	CbGeAlD
Lithium—GSK3A—adrenal cortex—hypothyroidism	0.00918	0.0231	CbGeAlD
Lithium—GSK3A—heart—hypothyroidism	0.00888	0.0223	CbGeAlD
Lithium—GRIA3—adrenal gland—hypothyroidism	0.0088	0.0221	CbGeAlD
Lithium—GSK3B—gonad—hypothyroidism	0.00875	0.022	CbGeAlD
Lithium—IMPA2—pituitary gland—hypothyroidism	0.0087	0.0219	CbGeAlD
Lithium—IMPA1—testis—hypothyroidism	0.00856	0.0215	CbGeAlD
Lithium—GSK3A—cardiovascular system—hypothyroidism	0.00838	0.0211	CbGeAlD
Lithium—GSK3B—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00829	0.0436	CbGpPWpGaD
Lithium—IMPA1—liver—hypothyroidism	0.00809	0.0203	CbGeAlD
Lithium—IMPA2—adrenal gland—hypothyroidism	0.00777	0.0195	CbGeAlD
Lithium—IMPA2—blood—hypothyroidism	0.00777	0.0195	CbGeAlD
Lithium—GSK3B—adrenal gland—hypothyroidism	0.00762	0.0192	CbGeAlD
Lithium—GSK3B—blood—hypothyroidism	0.00762	0.0192	CbGeAlD
Lithium—GSK3A—gonad—hypothyroidism	0.0076	0.0191	CbGeAlD
Lithium—IMPA2—thyroid gland—hypothyroidism	0.0075	0.0188	CbGeAlD
Lithium—GSK3A—pituitary gland—hypothyroidism	0.00742	0.0186	CbGeAlD
Lithium—GSK3B—thyroid gland—hypothyroidism	0.00735	0.0185	CbGeAlD
Lithium—GRIA3—testis—hypothyroidism	0.00728	0.0183	CbGeAlD
Lithium—IMPA2—female gonad—hypothyroidism	0.00724	0.0182	CbGeAlD
Lithium—GSK3B—female gonad—hypothyroidism	0.00711	0.0179	CbGeAlD
Lithium—GRIA3—liver—hypothyroidism	0.00688	0.0173	CbGeAlD
Lithium—GRIA3—cerebellum—hypothyroidism	0.00672	0.0169	CbGeAlD
Lithium—GSK3A—adrenal gland—hypothyroidism	0.00663	0.0167	CbGeAlD
Lithium—GSK3A—blood—hypothyroidism	0.00663	0.0167	CbGeAlD
Lithium—Coma—Levothyroxine—hypothyroidism	0.00651	0.0158	CcSEcCtD
Lithium—Coma—Dextrothyroxine—hypothyroidism	0.00651	0.0158	CcSEcCtD
Lithium—Arrhythmia—Liothyronine—hypothyroidism	0.0065	0.0158	CcSEcCtD
Lithium—IMPA2—testis—hypothyroidism	0.00642	0.0161	CbGeAlD
Lithium—GSK3A—thyroid gland—hypothyroidism	0.00639	0.0161	CbGeAlD
Lithium—GSK3B—testis—hypothyroidism	0.0063	0.0158	CbGeAlD
Lithium—GRIA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00619	0.0325	CbGpPWpGaD
Lithium—GSK3A—female gonad—hypothyroidism	0.00618	0.0155	CbGeAlD
Lithium—IMPA2—liver—hypothyroidism	0.00607	0.0153	CbGeAlD
Lithium—GSK3B—liver—hypothyroidism	0.00596	0.015	CbGeAlD
Lithium—GSK3B—cerebellum—hypothyroidism	0.00582	0.0146	CbGeAlD
Lithium—Oliguria—Liotrix—hypothyroidism	0.00568	0.0138	CcSEcCtD
Lithium—GSK3A—testis—hypothyroidism	0.00548	0.0138	CbGeAlD
Lithium—Muscle twitching—Liotrix—hypothyroidism	0.00533	0.0129	CcSEcCtD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0053	0.0279	CbGpPWpGaD
Lithium—GSK3A—liver—hypothyroidism	0.00518	0.013	CbGeAlD
Lithium—GSK3A—cerebellum—hypothyroidism	0.00506	0.0127	CbGeAlD
Lithium—Hypotension—Liothyronine—hypothyroidism	0.00483	0.0117	CcSEcCtD
Lithium—Dehydration—Levothyroxine—hypothyroidism	0.00481	0.0117	CcSEcCtD
Lithium—Dehydration—Dextrothyroxine—hypothyroidism	0.00481	0.0117	CcSEcCtD
Lithium—Coma—Liotrix—hypothyroidism	0.00479	0.0116	CcSEcCtD
Lithium—GRIA3—Neuronal System—SLC5A7—hypothyroidism	0.00474	0.0249	CbGpPWpGaD
Lithium—GSK3B—Signaling events mediated by Stem cell factor receptor (c-Kit)—SH2B3—hypothyroidism	0.00465	0.0245	CbGpPWpGaD
Lithium—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00456	0.0111	CcSEcCtD
Lithium—Muscular weakness—Levothyroxine—hypothyroidism	0.00456	0.0111	CcSEcCtD
Lithium—Swelling—Liotrix—hypothyroidism	0.00431	0.0105	CcSEcCtD
Lithium—Body temperature increased—Liothyronine—hypothyroidism	0.00409	0.00993	CcSEcCtD
Lithium—Weight decreased—Levothyroxine—hypothyroidism	0.00404	0.00981	CcSEcCtD
Lithium—Weight decreased—Dextrothyroxine—hypothyroidism	0.00404	0.00981	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00399	0.021	CbGpPWpGaD
Lithium—IMPA2—Metabolism—IYD—hypothyroidism	0.00368	0.0193	CbGpPWpGaD
Lithium—Dehydration—Liotrix—hypothyroidism	0.00354	0.00858	CcSEcCtD
Lithium—Muscular weakness—Liotrix—hypothyroidism	0.00335	0.00814	CcSEcCtD
Lithium—IMPA1—Metabolism—IYD—hypothyroidism	0.00328	0.0172	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.0032	0.0168	CbGpPWpGaD
Lithium—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00319	0.00776	CcSEcCtD
Lithium—Arrhythmia—Levothyroxine—hypothyroidism	0.00319	0.00776	CcSEcCtD
Lithium—Alopecia—Dextrothyroxine—hypothyroidism	0.00316	0.00767	CcSEcCtD
Lithium—Alopecia—Levothyroxine—hypothyroidism	0.00316	0.00767	CcSEcCtD
Lithium—IMPA2—Metabolism—ATP5O—hypothyroidism	0.00313	0.0164	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—NEFL—hypothyroidism	0.00306	0.0161	CbGpPWpGaD
Lithium—Weight decreased—Liotrix—hypothyroidism	0.00297	0.00722	CcSEcCtD
Lithium—IMPA2—Metabolism—TPO—hypothyroidism	0.00294	0.0155	CbGpPWpGaD
Lithium—Tremor—Dextrothyroxine—hypothyroidism	0.00292	0.00708	CcSEcCtD
Lithium—Tremor—Levothyroxine—hypothyroidism	0.00292	0.00708	CcSEcCtD
Lithium—Agitation—Dextrothyroxine—hypothyroidism	0.00286	0.00694	CcSEcCtD
Lithium—Agitation—Levothyroxine—hypothyroidism	0.00286	0.00694	CcSEcCtD
Lithium—Angioedema—Dextrothyroxine—hypothyroidism	0.00284	0.00691	CcSEcCtD
Lithium—Angioedema—Levothyroxine—hypothyroidism	0.00284	0.00691	CcSEcCtD
Lithium—GSK3A—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.00279	0.0147	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ATP5O—hypothyroidism	0.00279	0.0147	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—NKX2-1—hypothyroidism	0.0027	0.0142	CbGpPWpGaD
Lithium—Convulsion—Levothyroxine—hypothyroidism	0.0027	0.00655	CcSEcCtD
Lithium—Convulsion—Dextrothyroxine—hypothyroidism	0.0027	0.00655	CcSEcCtD
Lithium—Arthralgia—Levothyroxine—hypothyroidism	0.00265	0.00643	CcSEcCtD
Lithium—Arthralgia—Dextrothyroxine—hypothyroidism	0.00265	0.00643	CcSEcCtD
Lithium—GRIA3—BDNF signaling pathway—VAV3—hypothyroidism	0.00263	0.0138	CbGpPWpGaD
Lithium—IMPA1—Metabolism—TPO—hypothyroidism	0.00262	0.0138	CbGpPWpGaD
Lithium—Confusional state—Levothyroxine—hypothyroidism	0.00256	0.00622	CcSEcCtD
Lithium—Confusional state—Dextrothyroxine—hypothyroidism	0.00256	0.00622	CcSEcCtD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—PIK3C2A—hypothyroidism	0.00253	0.0133	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—PIK3C2A—hypothyroidism	0.00252	0.0133	CbGpPWpGaD
Lithium—Shock—Dextrothyroxine—hypothyroidism	0.0025	0.00607	CcSEcCtD
Lithium—Shock—Levothyroxine—hypothyroidism	0.0025	0.00607	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.00236	0.0124	CbGpPWpGaD
Lithium—Arrhythmia—Liotrix—hypothyroidism	0.00235	0.0057	CcSEcCtD
Lithium—Alopecia—Liotrix—hypothyroidism	0.00232	0.00564	CcSEcCtD
Lithium—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00231	0.00562	CcSEcCtD
Lithium—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00231	0.00562	CcSEcCtD
Lithium—Flatulence—Liotrix—hypothyroidism	0.00226	0.00548	CcSEcCtD
Lithium—Dysgeusia—Liotrix—hypothyroidism	0.00224	0.00544	CcSEcCtD
Lithium—Fatigue—Dextrothyroxine—hypothyroidism	0.00219	0.00532	CcSEcCtD
Lithium—Fatigue—Levothyroxine—hypothyroidism	0.00219	0.00532	CcSEcCtD
Lithium—Vision blurred—Liotrix—hypothyroidism	0.00216	0.00524	CcSEcCtD
Lithium—Tremor—Liotrix—hypothyroidism	0.00215	0.00521	CcSEcCtD
Lithium—Agitation—Liotrix—hypothyroidism	0.0021	0.00511	CcSEcCtD
Lithium—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00209	0.00508	CcSEcCtD
Lithium—Feeling abnormal—Levothyroxine—hypothyroidism	0.00209	0.00508	CcSEcCtD
Lithium—Angioedema—Liotrix—hypothyroidism	0.00209	0.00508	CcSEcCtD
Lithium—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00208	0.00504	CcSEcCtD
Lithium—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00208	0.00504	CcSEcCtD
Lithium—GSK3B—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.00206	0.0108	CbGpPWpGaD
Lithium—Syncope—Liotrix—hypothyroidism	0.00205	0.00498	CcSEcCtD
Lithium—Loss of consciousness—Liotrix—hypothyroidism	0.00201	0.00489	CcSEcCtD
Lithium—Body temperature increased—Levothyroxine—hypothyroidism	0.00201	0.00488	CcSEcCtD
Lithium—Abdominal pain—Levothyroxine—hypothyroidism	0.00201	0.00488	CcSEcCtD
Lithium—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00201	0.00488	CcSEcCtD
Lithium—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00201	0.00488	CcSEcCtD
Lithium—Convulsion—Liotrix—hypothyroidism	0.00198	0.00482	CcSEcCtD
Lithium—GSK3A—Signaling by ERBB4—PRL—hypothyroidism	0.00195	0.0102	CbGpPWpGaD
Lithium—Arthralgia—Liotrix—hypothyroidism	0.00195	0.00473	CcSEcCtD
Lithium—GSK3B—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.00191	0.01	CbGpPWpGaD
Lithium—Confusional state—Liotrix—hypothyroidism	0.00188	0.00457	CcSEcCtD
Lithium—Oedema—Liotrix—hypothyroidism	0.00187	0.00454	CcSEcCtD
Lithium—GSK3B—Insulin Signaling—PIK3C2A—hypothyroidism	0.00186	0.0098	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.00185	0.00973	CbGpPWpGaD
Lithium—Shock—Liotrix—hypothyroidism	0.00184	0.00446	CcSEcCtD
Lithium—Asthenia—Dextrothyroxine—hypothyroidism	0.00182	0.00443	CcSEcCtD
Lithium—Asthenia—Levothyroxine—hypothyroidism	0.00182	0.00443	CcSEcCtD
Lithium—Anorexia—Liotrix—hypothyroidism	0.00178	0.00432	CcSEcCtD
Lithium—Hypotension—Liotrix—hypothyroidism	0.00175	0.00424	CcSEcCtD
Lithium—Diarrhoea—Levothyroxine—hypothyroidism	0.00174	0.00422	CcSEcCtD
Lithium—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00174	0.00422	CcSEcCtD
Lithium—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.0017	0.00413	CcSEcCtD
Lithium—GSK3A—DAP12 signaling—VAV3—hypothyroidism	0.0017	0.00892	CbGpPWpGaD
Lithium—Decreased appetite—Liotrix—hypothyroidism	0.00162	0.00394	CcSEcCtD
Lithium—Vomiting—Dextrothyroxine—hypothyroidism	0.00162	0.00392	CcSEcCtD
Lithium—Vomiting—Levothyroxine—hypothyroidism	0.00162	0.00392	CcSEcCtD
Lithium—Fatigue—Liotrix—hypothyroidism	0.00161	0.00391	CcSEcCtD
Lithium—Rash—Levothyroxine—hypothyroidism	0.0016	0.00389	CcSEcCtD
Lithium—Rash—Dextrothyroxine—hypothyroidism	0.0016	0.00389	CcSEcCtD
Lithium—Dermatitis—Dextrothyroxine—hypothyroidism	0.0016	0.00389	CcSEcCtD
Lithium—Dermatitis—Levothyroxine—hypothyroidism	0.0016	0.00389	CcSEcCtD
Lithium—GSK3A—DAP12 interactions—VAV3—hypothyroidism	0.0016	0.00839	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.0016	0.00839	CbGpPWpGaD
Lithium—Headache—Levothyroxine—hypothyroidism	0.00159	0.00386	CcSEcCtD
Lithium—Headache—Dextrothyroxine—hypothyroidism	0.00159	0.00386	CcSEcCtD
Lithium—GSK3B—Signaling by Wnt—CLTC—hypothyroidism	0.00157	0.00826	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—CLTC—hypothyroidism	0.00154	0.00811	CbGpPWpGaD
Lithium—Feeling abnormal—Liotrix—hypothyroidism	0.00154	0.00374	CcSEcCtD
Lithium—Gastrointestinal pain—Liotrix—hypothyroidism	0.00153	0.00371	CcSEcCtD
Lithium—Nausea—Dextrothyroxine—hypothyroidism	0.00151	0.00366	CcSEcCtD
Lithium—Nausea—Levothyroxine—hypothyroidism	0.00151	0.00366	CcSEcCtD
Lithium—Body temperature increased—Liotrix—hypothyroidism	0.00148	0.00359	CcSEcCtD
Lithium—Abdominal pain—Liotrix—hypothyroidism	0.00148	0.00359	CcSEcCtD
Lithium—GSK3B—Signaling by ERBB4—PRL—hypothyroidism	0.00144	0.00757	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.0014	0.00735	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—VAV3—hypothyroidism	0.00139	0.00732	CbGpPWpGaD
Lithium—IMPA2—Metabolism—TSHB—hypothyroidism	0.00136	0.00716	CbGpPWpGaD
Lithium—Asthenia—Liotrix—hypothyroidism	0.00134	0.00325	CcSEcCtD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.00132	0.00693	CbGpPWpGaD
Lithium—Diarrhoea—Liotrix—hypothyroidism	0.00128	0.0031	CcSEcCtD
Lithium—GSK3B—Corticotropin-releasing hormone—POMC—hypothyroidism	0.00128	0.0067	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CLTC—hypothyroidism	0.00126	0.00665	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—VAV3—hypothyroidism	0.00125	0.00659	CbGpPWpGaD
Lithium—Dizziness—Liotrix—hypothyroidism	0.00124	0.003	CcSEcCtD
Lithium—IMPA2—Metabolism—PIK3C2A—hypothyroidism	0.00121	0.00638	CbGpPWpGaD
Lithium—IMPA1—Metabolism—TSHB—hypothyroidism	0.00121	0.00638	CbGpPWpGaD
Lithium—Vomiting—Liotrix—hypothyroidism	0.00119	0.00288	CcSEcCtD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.00118	0.0062	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—VAV3—hypothyroidism	0.00118	0.0062	CbGpPWpGaD
Lithium—Rash—Liotrix—hypothyroidism	0.00118	0.00286	CcSEcCtD
Lithium—Dermatitis—Liotrix—hypothyroidism	0.00118	0.00286	CcSEcCtD
Lithium—Headache—Liotrix—hypothyroidism	0.00117	0.00284	CcSEcCtD
Lithium—Nausea—Liotrix—hypothyroidism	0.00111	0.00269	CcSEcCtD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.0011	0.0058	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CLTC—hypothyroidism	0.0011	0.00579	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—VAV3—hypothyroidism	0.00109	0.00572	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PIK3C2A—hypothyroidism	0.00108	0.00568	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—AVP—hypothyroidism	0.00103	0.0054	CbGpPWpGaD
Lithium—IMPA2—Metabolism—SLC5A5—hypothyroidism	0.00102	0.00536	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CLTC—hypothyroidism	0.000934	0.00491	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000926	0.00486	CbGpPWpGaD
Lithium—IMPA1—Metabolism—SLC5A5—hypothyroidism	0.000908	0.00477	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—TSHB—hypothyroidism	0.000886	0.00466	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—VAV3—hypothyroidism	0.000804	0.00423	CbGpPWpGaD
Lithium—GSK3A—Immune System—CLTC—hypothyroidism	0.000767	0.00403	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—VAV3—hypothyroidism	0.000728	0.00382	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—IGF1—hypothyroidism	0.000687	0.00361	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—VAV3—hypothyroidism	0.000621	0.00326	CbGpPWpGaD
Lithium—GSK3B—Immune System—CLTC—hypothyroidism	0.000567	0.00298	CbGpPWpGaD
Lithium—IMPA2—Metabolism—POMC—hypothyroidism	0.000533	0.0028	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—VAV3—hypothyroidism	0.000519	0.00273	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CLTC—hypothyroidism	0.000496	0.00261	CbGpPWpGaD
Lithium—IMPA1—Metabolism—POMC—hypothyroidism	0.000475	0.0025	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—VAV3—hypothyroidism	0.000459	0.00241	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TRH—hypothyroidism	0.000429	0.00225	CbGpPWpGaD
Lithium—GSK3A—Immune System—PRL—hypothyroidism	0.000391	0.00205	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TSHB—hypothyroidism	0.000382	0.00201	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TSHR—hypothyroidism	0.000382	0.00201	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CLTC—hypothyroidism	0.000366	0.00193	CbGpPWpGaD
Lithium—GSK3A—Immune System—VAV3—hypothyroidism	0.000361	0.0019	CbGpPWpGaD
Lithium—GSK3A—Disease—PRL—hypothyroidism	0.000361	0.0019	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—POMC—hypothyroidism	0.000347	0.00182	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SH2B3—hypothyroidism	0.00034	0.00179	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGF1—hypothyroidism	0.000334	0.00176	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TRH—hypothyroidism	0.000317	0.00166	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRL—hypothyroidism	0.000289	0.00152	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TSHB—hypothyroidism	0.000282	0.00148	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TSHR—hypothyroidism	0.000282	0.00148	CbGpPWpGaD
Lithium—GSK3B—Immune System—VAV3—hypothyroidism	0.000267	0.0014	CbGpPWpGaD
Lithium—GSK3B—Disease—PRL—hypothyroidism	0.000267	0.0014	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRL—hypothyroidism	0.000253	0.00133	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SH2B3—hypothyroidism	0.000252	0.00132	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VAV3—hypothyroidism	0.000234	0.00123	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AVP—hypothyroidism	0.000225	0.00118	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRL—hypothyroidism	0.000187	0.000981	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VAV3—hypothyroidism	0.000173	0.000908	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AVP—hypothyroidism	0.000166	0.000874	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—hypothyroidism	0.00015	0.000786	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—hypothyroidism	0.000144	0.000756	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—hypothyroidism	0.000111	0.000581	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—hypothyroidism	0.000106	0.000559	CbGpPWpGaD
